Financially Speaking’s Gilead Sciences GILD Stock Holding History

Financially Speaking’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22K	Hold	158	–	–	0.11%	47
2026 Q1	$22K	Sell	158 -24	-13%	-$3.36K	0.11%	47
2025 Q4	$22.3K	Hold	182	–	–	0.01%	86
2025 Q3	$20.2K	Hold	182	–	–	0.01%	85
2025 Q2	$20.2K	Buy	+182	New	+$19.4K	0.01%	74
2025 Q1	–	Sell	-540	Closed	-$49.9K	–	106
2024 Q4	$49.9K	Buy	+540	New	+$48.6K	0.03%	52

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Financially Speaking's GILD Position: Q2 2026 in Review

Financially Speaking held its Gilead Sciences (GILD) position steady in Q2 2026 at 158 shares worth $22K. The position accounts for 0.11% of the portfolio, ranked #47.

Financially Speaking first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. The position peaked at $49.9K in Q4 2024. 775 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Financially Speaking held 158 shares of Gilead Sciences worth $22K as of Q2 2026.
Financially Speaking left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.11% of Financially Speaking's portfolio in Q2 2026, its #47 holding.
Financially Speaking first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
Financially Speaking's Gilead Sciences position peaked at $49.9K in Q4 2024.
775 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Financially Speaking's 13F filing for Q2 2026, filed 27 Jul 2026.